These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 2180267)

  • 21. [Cost-effectiveness of lowering of blood cholesterol using simvastatin and cholestyramine].
    Martens LL; Rutten FF; Kuijpens JL; Winter J
    Ned Tijdschr Geneeskd; 1991 Apr; 135(15):655-9. PubMed ID: 1903849
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HMG CoA reductase inhibitors as lipid-lowering agents: five years experience with lovastatin and an appraisal of simvastatin and pravastatin.
    Maher VM; Thompson GR
    Q J Med; 1990 Feb; 74(274):165-75. PubMed ID: 2111917
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lovastatin and simvastatin prevention studies.
    Jones PH
    Am J Cardiol; 1990 Sep; 66(8):39B-43B. PubMed ID: 2206035
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combination drug therapy with HMG CoA reductase inhibitors and bile acid sequestrants for hypercholesterolemia.
    Erkelens DW
    Cardiology; 1990; 77 Suppl 4():33-8. PubMed ID: 2073670
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Choice of cholesterol-lowering drugs.
    Med Lett Drugs Ther; 1993 Mar; 35(891):19-22. PubMed ID: 8433674
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparative effects of simvastatin and cholestyramine in treatment of patients with hypercholesterolaemia.
    Mölgaard J; von Schenck H; Olsson AG
    Eur J Clin Pharmacol; 1989; 36(5):455-60. PubMed ID: 2502417
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Simvastatin therapy for hypercholesterolaemia in patients with coronary heart disease.
    French JK; White HD; Greaves SC
    N Z Med J; 1990 Feb; 103(883):41-3. PubMed ID: 2304688
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the effects of lovastatin and gemfibrozil on lipids and glucose control in non-insulin-dependent diabetes mellitus.
    Goldberg R; La Belle P; Zupkis R; Ronca P
    Am J Cardiol; 1990 Sep; 66(8):16B-21B. PubMed ID: 2206032
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of three fibrate derivatives and of two HMG-CoA reductase inhibitors on plasma fibrinogen level in patients with primary hypercholesterolemia.
    Branchi A; Rovellini A; Sommariva D; Gugliandolo AG; Fasoli A
    Thromb Haemost; 1993 Aug; 70(2):241-3. PubMed ID: 8236126
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Efficacy and safety of simvastatin, a new cholesterol-lowering drug].
    Mol MJ; Stuyt PM; Stalenhoef AF
    Ned Tijdschr Geneeskd; 1989 Feb; 133(7):362-6. PubMed ID: 2927555
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low density lipoprotein density and composition in hypercholesterolaemic men treated with HMG CoA reductase inhibitors and gemfibrozil.
    Tilly-Kiesi M; Tikkanen MJ
    J Intern Med; 1991 May; 229(5):427-34. PubMed ID: 2040869
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lipid control with low-dosage simvastatin in patients with moderate hypercholesterolaemia. An Italian multicentre double-blind placebo-controlled study.
    Capurso A; Resta F; Bertolini S; Masturzo P; Feruglio FS; Cattin L; Da Col PG; Descovich GC; Gaddi A; Urbinati GC
    Eur Heart J; 1992 Jul; 13 Suppl B():11-6. PubMed ID: 1644094
    [No Abstract]   [Full Text] [Related]  

  • 33. [HMG-CoA reductase inhibitors in familial hypercholesterolemia. Therapy with simvastatin alone and in combination with cholestyramine in low dosage; a report of 2 years experiences].
    Geisel J; Oette K; Burrichter H
    Fortschr Med; 1990 Feb; 108(4):71-2, 75-6. PubMed ID: 2312032
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reducing high blood cholesterol level with drugs. Cost-effectiveness of pharmacologic management.
    Schulman KA; Kinosian B; Jacobson TA; Glick H; Willian MK; Koffer H; Eisenberg JM
    JAMA; 1990 Dec; 264(23):3025-33. PubMed ID: 2123013
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Simvastatin in the treatment of hypercholesterolemia].
    Cigala O; Pancallo MT; Della Valle M; Marasco A; Malarbi AL
    Clin Ter; 1991 Jun; 137(5):333-7. PubMed ID: 1832606
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparison between lovastatin and gemfibrozil in the treatment of primary hypercholesterolemia.
    D'Agostino RB; Kannel WB; Stepanians MN; D'Agostino LC
    Am J Cardiol; 1992 Jan; 69(1):28-34. PubMed ID: 1729864
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical experience with simvastatin compared with cholestyramine.
    Erkelens DW; Baggen MG; Van Doormaal JJ; Kettner M; Koningsberger JC; Mol MJ
    Drugs; 1988; 36 Suppl 3():87-92. PubMed ID: 3254824
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and safety of triple therapy (fluvastatin-bezafibrate-cholestyramine) for severe familial hypercholesterolemia.
    Leitersdorf E; Muratti EN; Eliav O; Peters TK
    Am J Cardiol; 1995 Jul; 76(2):84A-88A. PubMed ID: 7604807
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential effects of lipid-lowering therapies on stroke prevention: a meta-analysis of randomized trials.
    Corvol JC; Bouzamondo A; Sirol M; Hulot JS; Sanchez P; Lechat P
    Arch Intern Med; 2003 Mar; 163(6):669-76. PubMed ID: 12639199
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HMGCoA reductase inhibitors lovastatin and simvastatin in the treatment of hypercholesterolemia after renal transplantation.
    Castelao AM; Griñó JM; Andrés E; Gilvernet S; Serón D; Castiñeiras MJ; Roca M; Galcerán JM; González MT; Alsina J
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1043-6. PubMed ID: 8442035
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.